Vaccines in 2017: Closing in on a Zika virus vaccine.

dc.contributor.author

Diamond, Michael S

dc.contributor.author

Coyne, Carolyn B

dc.date.accessioned

2021-04-16T19:58:42Z

dc.date.available

2021-04-16T19:58:42Z

dc.date.issued

2018-02

dc.date.updated

2021-04-16T19:58:41Z

dc.identifier

nri.2017.132

dc.identifier.issn

1474-1733

dc.identifier.issn

1474-1741

dc.identifier.uri

https://hdl.handle.net/10161/22586

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Nature reviews. Immunology

dc.relation.isversionof

10.1038/nri.2017.132

dc.subject

CD8-Positive T-Lymphocytes

dc.subject

Animals

dc.subject

Humans

dc.subject

Vaccines, Attenuated

dc.subject

Vaccines, Subunit

dc.subject

Viral Vaccines

dc.subject

Immunologic Techniques

dc.subject

Pregnancy

dc.subject

Adult

dc.subject

Infant, Newborn

dc.subject

Female

dc.subject

Drug Discovery

dc.subject

Zika Virus

dc.subject

Zika Virus Infection

dc.title

Vaccines in 2017: Closing in on a Zika virus vaccine.

dc.type

Journal article

duke.contributor.orcid

Coyne, Carolyn B|0000-0002-1884-6309

pubs.begin-page

89

pubs.end-page

90

pubs.issue

2

pubs.organisational-group

School of Medicine

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Duke

pubs.organisational-group

Basic Science Departments

pubs.publication-status

Published

pubs.volume

18

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nri.2017.132.pdf
Size:
439.73 KB
Format:
Adobe Portable Document Format